Shear stress control of vascular leaks and atheromas through Tie2 activation by VE-PTP sequestration.

Autor: Shirakura K; Max Planck Institute for Molecular Biomedicine, Münster, Germany., Baluk P; Cardiovascular Research Institute, UCSF Helen Diller Family Comprehensive Cancer Center, and Department of Anatomy, University of California, San Francisco, San Francisco, CA, USA., Nottebaum AF; Max Planck Institute for Molecular Biomedicine, Münster, Germany., Ipe U; Max Planck Institute for Molecular Biomedicine, Münster, Germany., Peters KG; Aerpio Therapeutics, Inc., Blue Ash, OH, USA., McDonald DM; Cardiovascular Research Institute, UCSF Helen Diller Family Comprehensive Cancer Center, and Department of Anatomy, University of California, San Francisco, San Francisco, CA, USA., Vestweber D; Max Planck Institute for Molecular Biomedicine, Münster, Germany.

Publikováno v: EMBO molecular medicine [EMBO Mol Med] 2023 Apr 11; Vol. 15 (4), pp. e16128. Date of Electronic Publication: 2023 Feb 06.

Force-induced changes of α-catenin conformation stabilize vascular junctions independently of vinculin.

Autor: Duong CN; Department of Vascular Cell Biology, Max Planck Institute for Molecular Biomedicine, D-48149 Münster, Germany., Brückner R; Department of Vascular Cell Biology, Max Planck Institute for Molecular Biomedicine, D-48149 Münster, Germany., Schmitt M; Department of Vascular Cell Biology, Max Planck Institute for Molecular Biomedicine, D-48149 Münster, Germany., Nottebaum AF; Department of Vascular Cell Biology, Max Planck Institute for Molecular Biomedicine, D-48149 Münster, Germany., Braun LJ; Department of Vascular Cell Biology, Max Planck Institute for Molecular Biomedicine, D-48149 Münster, Germany., Meyer Zu Brickwedde M; Department of Vascular Cell Biology, Max Planck Institute for Molecular Biomedicine, D-48149 Münster, Germany., Ipe U; Department of Vascular Cell Biology, Max Planck Institute for Molecular Biomedicine, D-48149 Münster, Germany., Vom Bruch H; Department of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, D-48149 Münster, Germany., Schöler HR; Department of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, D-48149 Münster, Germany., Trapani G; Bioactive Materials Laboratory, Max Planck Institute for Molecular Biomedicine, D-48149 Münster, Germany., Trappmann B; Bioactive Materials Laboratory, Max Planck Institute for Molecular Biomedicine, D-48149 Münster, Germany., Ebrahimkutty MP; Institute of Medical Physics and Biophysics, University of Muenster, Muenster 48149, Germany., Huveneers S; Amsterdam University Medical Center, Location AMC, University of Amsterdam, Amsterdam, The Netherlands., de Rooij J; Center for Molecular Medicine, University Medical Center Utrecht, 3584 CG Utrecht, The Netherlands., Ishiyama N; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada., Ikura M; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada., Vestweber D; Department of Vascular Cell Biology, Max Planck Institute for Molecular Biomedicine, D-48149 Münster, Germany.

Publikováno v: Journal of cell science [J Cell Sci] 2021 Dec 15; Vol. 134 (24). Date of Electronic Publication: 2021 Dec 22.

Insights to Ang/Tie signaling pathway: another rosy dawn for treating retinal and choroidal vascular diseases.

Autor: Sha, Lulu^1,2 (AUTHOR), Zhao, Yameng^1,2 (AUTHOR), Li, Siyu² (AUTHOR), Wei, Dong² (AUTHOR), Tao, Ye¹ (AUTHOR) panghtoyezz@zzu.edu.cn, Wang, Yange¹ (AUTHOR) wangyange123@zzu.edu.cn

Publikováno v: Journal of Translational Medicine. 10/4/2024, Vol. 22 Issue 1, p1-23. 23p.

A Small Molecule Inhibitor of VE-PTP Activates Tie2 in Schlemm's Canal Increasing Outflow Facility and Reducing Intraocular Pressure.

Autor: Li G; Department of Ophthalmology, Department of Biomedical Engineering, Duke University, Durham, North Carolina, United States., Nottebaum AF; Max Planck Institute of Molecular Biomedicine, Muenster, Germany., Brigell M; Aerpio Pharmaceuticals, Inc., Cincinnati, Ohio, United States., Navarro ID; Department of Ophthalmology, Department of Biomedical Engineering, Duke University, Durham, North Carolina, United States., Ipe U; Max Planck Institute of Molecular Biomedicine, Muenster, Germany., Mishra S; Max Planck Institute of Molecular Biomedicine, Muenster, Germany., Gomez-Caraballo M; Department of Ophthalmology, Department of Biomedical Engineering, Duke University, Durham, North Carolina, United States., Schmitt H; Department of Ophthalmology, Department of Biomedical Engineering, Duke University, Durham, North Carolina, United States., Soldo B; Aerpio Pharmaceuticals, Inc., Cincinnati, Ohio, United States., Pakola S; Aerpio Pharmaceuticals, Inc., Cincinnati, Ohio, United States., Withers B; Aerpio Pharmaceuticals, Inc., Cincinnati, Ohio, United States., Peters KG; Aerpio Pharmaceuticals, Inc., Cincinnati, Ohio, United States., Vestweber D; Max Planck Institute of Molecular Biomedicine, Muenster, Germany., Stamer WD; Department of Ophthalmology, Department of Biomedical Engineering, Duke University, Durham, North Carolina, United States.

Publikováno v: Investigative ophthalmology & visual science [Invest Ophthalmol Vis Sci] 2020 Dec 01; Vol. 61 (14), pp. 12.

China's Stock Market under COVID-19: From the Perspective of Behavioral Finance.

Autor: Li, Kaizheng¹ (AUTHOR) s1327117@live.hkmu.edu.hk, Jiang, Xiaowen² (AUTHOR) jxw@ncut.edu.cn

Publikováno v: International Journal of Financial Studies. Sep2024, Vol. 12 Issue 3, p70. 19p.